Tema Heart & Health ETF (HRTS)
NasdaqGM: HRTS
· リアルタイム株価 · USD
37.44
-0.26 (-0.69%)
終値時点： Aug 13, 2026, 3:36 PM
Tema Heart & Health ETF (HRTS) ETF Price, Holdings & Analysis
-0.69% (1D)
| 買気配 | 26.28 |
| 時価総額 | n/a |
| 純資産総額 | 54.27M |
| 基準価額 | 37.74 |
| ベータ | n/a |
| EPS（過去12か月） | n/a |
| PER（過去12か月） | 25.45 |
| 発行済口数 | n/a |
| 設定日 | Nov 20, 2023 |
| 売気配 | 47.47 |
| 出来高 | 2,154 |
| 平均出来高（20日） | 5,737 |
| 始値 | 37.78 |
| 前日終値 | 37.70 |
| 日中値幅 | 37.42 - 37.78 |
| 52週の値幅 | 28.40 - 37.82 |
| 組入銘柄 | n/a |
| 経費率 | 0.75% |
HRTSについて
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
上位10銘柄 純資産の48.89%
| 名称 | シンボル | 構成比 |
|---|---|---|
| Eli Lilly And Co | LLY | 11.32% |
| Unitedhealth Group I... | UNH | 5.50% |
| Novo Nordisk As Clas... | NOVO-B.CO | 5.12% |
| Thermo Fisher Scient... | TMO | 4.54% |
| Roche Holding Ag Adr | RHHBY | 4.18% |
| Merck & Co Inc | MRK | 4.16% |
| Johnson & Johnson | JNJ | 3.86% |
| Astrazeneca PLC | AZN.L | 3.46% |
| Revolution Medicines... | RVMD | 3.44% |
| Novartis Ag Register... | NOVN.SW | 3.31% |
